Lincoln National Corp Biogen Inc. Transaction History

Lincoln National Corp

$6.26 Billion
Q1 2024

A detailed history of Lincoln National Corp transactions in Biogen Inc. stock. As of the latest transaction made, Lincoln National Corp holds 1,157 shares of BIIB stock, worth $263,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,157

Previous 1,212 4.54%

Holding current value

$263,876

Previous $313,000 20.45%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$212.02 - $267.71 $11,661 - $14,724	-55 Reduced 4.54%	1,157 $249,000
Q4 2023 Feb 06, 2024	SELL	$222.59 - $267.94 $54,311 - $65,377	-244 Reduced 16.76%	1,212 $313,000
Q3 2023 Nov 03, 2023	SELL	$253.3 - $285.89 $2.12 Million - $2.39 Million	-8,363 Reduced 85.17%	1,456 $374,000
Q2 2023 Aug 04, 2023	SELL	$275.25 - $318.06 $89,181 - $103,051	-324 Reduced 3.19%	9,819 $2.8 Million
Q1 2023 May 01, 2023	BUY	$256.56 - $292.34 $447,184 - $509,548	1,743 Added 20.75%	10,143 $2.82 Million

Q4 2022 Feb 07, 2023	BUY	$252.44 - $306.72 $2.12 Million - $2.58 Million	8,400 New	8,400 $2.33 Million
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $217,216 - $273,680	-1,121 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$223.92 - $287.77 $8,061 - $10,359	36 Added 3.32%	1,121 $269,000
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $543,340 - $708,576	-1,920 Reduced 63.89%	1,085 $307,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $486,402 - $778,825	1,878 Added 166.64%	3,005 $1.04 Million
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $77,258 - $90,512	-318 Reduced 22.01%	1,127 $315,000
Q4 2020 Feb 05, 2021	SELL	$236.26 - $355.63 $88,597 - $133,361	-375 Reduced 20.6%	1,445 $354,000
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $67,251 - $77,650	254 Added 16.22%	1,820 $516,000
Q2 2020 Jul 31, 2020	BUY	$258.66 - $342.55 $183,131 - $242,525	708 Added 82.52%	1,566 $419,000
Q1 2020 Apr 24, 2020	BUY	$268.85 - $341.04 $806 - $1,023	3 Added 0.35%	858 $272,000
Q4 2019 Feb 07, 2020	BUY	$220.06 - $304.07 $188,151 - $259,979	855 New	855 $254,000
Q3 2019 Nov 06, 2019	SELL	$217.44 - $243.88 $223,963 - $251,196	-1,030 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$219.29 - $241.72 $21,709 - $23,930	-99 Reduced 8.77%	1,030 $241,000
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $244,665 - $382,685	1,129 New	1,129 $267,000
Q1 2018 May 09, 2018	SELL	$260.13 - $367.91 $250,245 - $353,929	-962 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $295,949 - $331,485	962	962 $306,000

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Account

Lincoln National Corp Biogen Inc. Transaction History